(Q35563775)

8 August 2017

title

In vitro activity of DR-3355, an optically active ofloxacin (English)

1 reference

8 August 2017

1 reference

Une T

1

1 reference

8 August 2017

Fujimoto T

series ordinal

2

1 reference

8 August 2017

Sato K

series ordinal

3

1 reference

8 August 2017

Osada Y

series ordinal

4

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 1988

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

published in

1 reference

8 August 2017

volume

32

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

1336-1340

1 reference

Method of reliable determination of minimal lethal antibiotic concentrations

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

In vitro and in vivo activity of DL-8280, a new oxazine derivative

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

In vitro and in vivo activity of NY-198, a new difluorinated quinolone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

Synthesis and antibacterial activities of optically active ofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

Inhibition of DNA gyrase by optically active ofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175863

Synthesis, absolute configuration, and antibacterial activity of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H- benzo[ij]quinolizine-2-carboxylic acid

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3195996

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3195996

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.32.9.1336

1 reference

8 August 2017

1 reference

8 August 2017

1 reference